E-LIB Suche - Ergebnisse für: García Merino, Juan Antonio

1

Disease modifying therapy switching in relapsing multiple s..:

Brieva, Luis ; Estruch, Bonaventura Casanova ; Merino, Juan Antonio García...
Multiple Sclerosis and Related Disorders. 63 (2022) - p. 103805 , 2022

Link: https://doi.org/10.1016/..

2

Guillain-Barré syndrome following the 2009 pandemic monoval..:

Spanish GBS Epidemiology Study Group ; Alcalde-Cabero, Enrique ; Almazán-Isla, Javier...
BMC Neurology. 16 (2016) 1 - p. , 2016

Link: https://doi.org/10.1186/..

3

Brain region volumes and their relationship with disability..:

Pérez-Miralles, Francisco Carlos ; Prefasi, Daniel ; García Merino, Juan Antonio...
info:eu-repo/semantics/altIdentifier/doi/10.1002/brb3.2044. , 2021

Link: http://hdl.handle.net/10..

4

CSF Chitinase 3–Like 2 Is Associated With Long-term Disabil..:

Comabella, Manuel ; Sastre Garriga, Jaume ; Borràs, Eva...
Reproducció del document publicat a: https://doi.org/10.1212/NXI.0000000000001082. , 2021

Link: http://hdl.handle.net/24..

5

Tolerability and safety of dimethyl fumarate in relapsing m..:

DMF Study Group ; Sabin, Julia ; Urtiaga, Sarai...
Journal of Neurology. 267 (2020) 8 - p. 2362-2371 , 2020

Link: https://doi.org/10.1007/..

6

Exome sequencing study in patients with multiple sclerosis ..:

Gil-Varea, Elia ; Urcelay, Elena ; Vilariño-Güell, Carles...
Journal of Neuroinflammation. 15 (2018) 1 - p. , 2018

Link: https://doi.org/10.1186/..

7

Guía de tratamiento del deterioro de la marcha con fampridi..:

Ramió i Torrentà, Lluís ; Álvarez Cermeño, José Carlos ; Arroyo, R...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.nrl.2015.11.013. , 2018

Link: http://hdl.handle.net/10..

8

Guillain-Barré syndrome following the 2009 pandemic monoval..:

Alcalde-Cabero, Enrique ; Almazán-Isla, Javier ; García López, Fernando J...
http://bmcneurol.biomedcentral.com/articles/10.1186/s12883-016-0598-z#Abs1. , 2016

Link: http://hdl.handle.net/10..

9

Guillain-Barré syndrome following the 2009 pandemic monoval..:

Alcalde Cabero, Enrique ; Almazan Isla, Javier ; García López, Fernando J...
Reproducció del document publicat a: https://doi.org/10.1186/s12883-016-0598-z. , 2016

Link: http://hdl.handle.net/24..

10

Long-Term Adherence to IFN Beta-1a Treatment when Using Reb..:

Fernández, O ; Arroyo, R ; Martínez Yélamos, Sergio...
Reproducció del document publicat a: https://doi.org/10.1371/journal.pone.0160313. , 2016

Link: http://hdl.handle.net/24..

11

Chitinase 3-like 1: prognostic biomarker in clinically isol..:

Cantó, Ester ; Tintoré, Mar ; Villar, Luisa M....
Brain. 138 (2015) 4 - p. 918-931 , 2015

Link: https://doi.org/10.1093/..

12

The cannabinoid system in human mesenchymal cells:

García, Coral González ; Vega, Laura Román ; Ruíz, Lucía Campos...
Journal of Neuroimmunology. 275 (2014) 1-2 - p. 189-190 , 2014

Link: https://doi.org/10.1016/..

13

Therapeutic potential of human mesenchymal cells from Multi..:

García, Coral González ; Vega, Laura Román ; Ruíz, Lucía Campos...
Journal of Neuroimmunology. 275 (2014) 1-2 - p. 190 , 2014

Link: https://doi.org/10.1016/..

14

Lipid-Specific IgM Bands Contribute To Stratify PML Risk in..:

Villar, Luisa ; Costa-Frossard, Lucienne ; Masterman, Thomas...
Neurology. 82 (2014) 10_supplement - p. , 2014

Link: https://doi.org/10.1212/..

15

Selective Induction of cAMP Phosphodiesterase PDE4B2 Expres..:

Reyes-Irisarri, Elisabet ; Sánchez, Antonio J. ; García-Merino, Juan Antonio.
Journal of Neuropathology and Experimental Neurology. 66 (2007) 10 - p. 923-931 , 2007

Link: https://doi.org/10.1097/..